TNDM Advancing Diabetes Technology With Ultra-Rapid Acting Insulin The t:slim X2 insulin pump, equipped with Control-IQ AID technology, is recognized for its ability to improve diabetes management ...

Control-IQ+, compatible with both the t:slim X2 insulin pump and Tandem Mobi System, is now available for people with type 1 diabetes ages 2 years and older and adults with type 2 diabetes.

With equity markets reeling due to President Donald Trump's tariffs, many investors are taking this opportunity to buy shares ...

A new clinical trial led by the Jaeb Center for Health Research has shown that automated insulin delivery (AID) systems can ...

The AID system used in the study was Tandem Diabetes Care's t:slim X2 insulin pump with Control-IQ+ technology, used in conjunction with a Dexcom G6 CGM sensor that can be used with NovoLog or ...

Tandem Diabetes (TNDM) announced the United States commercial launch of Control-IQ+ technology, the latest generation of the company’s advanced ...

The Control-IQ+ algorithm enables AID in conjunction with Tandem’s t:slim X2 and Mobi insulin pumps and a compatible continuous glucose monitor (CGM). The updated algorithm allows for a wider ...